November 14, 2007 - Safeway Inc. and the Prostate Cancer Foundation will announce a major joint gift to launch a landmark research initiative for prostate cancer Thursday, Nov.15, 2007 at the U.S. Chamber of Commerce in Washington, DC.
The S.T.A.R. Program (for Special Team Amplification of Research) will bring together an interdisciplinary team of investigators from Johns Hopkins, University of Michigan Cancer Center, University of British Columbia, University of Washington, and M.D. Anderson Cancer Center (Houston) and four other research partners. S.T.A.R. team members will explore the role of targeted heat in cancer therapy, using nanotechnology and other mechanisms, to treat prostate cancer.
The forum may be viewed live at www.uschamber.com/webcasts.
- Steve Burd, Chairman, President and CEO, Safeway Inc.
- Michael Milken, Chairman, The Milken Institute
- Jonathan W. Simons, M.D., CEO and President, David H. Koch Chair, Prostate Cancer Foundation
- Robert Getzenberg, Ph.D., Professor and Director of Research,Brady Urological Institute, Johns Hopkins University School of Medicine
- Donald Coffey, Ph.D., Professor of Urology, Oncology, Pathology, Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine
-Representative Mike Rogers (R-MI)
For more information: www.prostatecancerfoundation.org